Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, Richard K., Lissen, Eduardo, Clumeck, Nathan, Sola, Ricard, Correa, Mendes Cassia, Montaner, Julio, S. Sulkowski, Mark, Torriani, Francesca J., Dieterich, Doug T., Thomas, David L., Messinger, Diethelm, Nelson, Mark·2006·Hepatology

DOI 10.1002/hep.21178

Cited by (1,007)

Items 701–800 of 1,007

Intriguing findings of liver fibrosis following COVID-19
Oksana Koļesova, Иева Ванага, Sniedze Laivacuma, Aleksejs Derovs, Aleksandrs Koļesovs, Maija Radziņa, Ardis Platkājis, Jeļena Eglīte, Elvira Hagina, Seda Arutjuņana et al. · 2021 · BMC Gastroenterology
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
Takanori Ito, Vy H. Nguyen, Taku Tanaka, Huiyul Park, Ming‐Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen Laureal Yoon, Pei‐Chien Tsai et al. · 2022 · Clinical Gastroenterology and Hepatology
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
Chih‐Lin Lin, Chen‐Hua Liu, Chia‐Chi Wang, Cheng‐Chao Liang, Tung‐Hung Su, Chun‐Jen Liu, Jia‐Horng Kao · 2014 · Journal of Clinical Gastroenterology
Non‐alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community‐based Polish survey
Marek Hartleb, Kamil Barański, Jan Eugeniusz Zejda, Jerzy Tadeusz Chudek, Andrzej Więcek · 2017 · Liver International
Incretin-based investigational therapies for the treatment of MASLD/MASH
Brouwers, Bram, Rao, Girish, Tang, Yuanyuan, Rodríguez, Ángel, Glass, Leonard C, Hartman, Mark L · 2024 · Diabetes Research and Clinical Practice
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response
Kian Bichoupan, Valérie Martel‐Laferrière, David M Sachs, Michel Ng, Emily A. Schonfeld, Alexis Pappas, James F. Crismale, Alicia C. Stivala, Viktoriya Khaitova, Donald Gardenier et al. · 2014 · Hepatology
Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens
Norio Akuta, Hitomi Sezaki, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki et al. · 2017 · Journal of Medical Virology
The Predictive Role of Model for End‐Stage Liver Disease–Lactate and Lactate Clearance for In‐Hospital Mortality Among a National Cirrhosis Cohort
Nadim Mahmud, Sumeet K. Asrani, David Edward Kaplan, Gerald Ogola, Tamar Hamosh Taddei, Patrick S. Kamath, Marina Serper · 2020 · Liver Transplantation
Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis
Alyssa Y. Choi, Kenneth J. Chang, Jason Samarasena, John G. Lee, Xiaodong Li, Wenchang Guo, Vishal Suresh Chandan, Ke‐Qin Hu · 2022 · Digestive Diseases and Sciences
Serum biomarkers for liver fibrosis
Zhiyang Chen, Yichen Ma, Jingyao Cai, Mei Sun, Ling Zeng, Fengxi Wu, Yiru Zhang, Min Hu · 2022 · Clinica Chimica Acta
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
Chia‐Chi Wang, Chen‐Hua Liu, Chih‐Lin Lin, Pin‐Chao Wang, Tai‐Chung Tseng, Hans Hsienhong Lin, Jia‐Horng Kao · 2015 · Journal of the Formosan Medical Association
Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis
Giorgio Sesti, Angela Sciacqua, Teresa Vanessa Fiorentino, Maria Perticone, Elena Succurro, Francesco Perticone · 2014 · PLoS ONE
Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus
Juan Berenguer, Francisco X. Zamora, Teresa Aldámiz‐Echevarría, Miguel Ángel von Wichmann, M. Crespo Casal, José López‐Aldeguer, Ana Carrero, Marisa Montes, Carmen Quereda, Marı́a José Galindo et al. · 2014 · Clinical Infectious Diseases
Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence
Qing Pang · 2015 · World Journal of Gastroenterology
Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus‐infected patients with a sustained virological response
Yoshihiko Tachi, T. Hirai, Y. Kojima, Akihiro Miyata, Kuniaki Ohara, Yoji Ishizu, Takashi Honda, Teiji Kuzuya, Kazuhiko Hayashi, Masatoshi Ishigami et al. · 2016 · Alimentary Pharmacology & Therapeutics
Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES
Adeel Ajwad Butt, Yanjie Ren, Vincent Lo Re, Tamar Hamosh Taddei, David Edward Kaplan · 2017 · Clinical Infectious Diseases
Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis
Marcello Persico, Valerio Rosato, Andrea Aglitti, Davide Ferdinando Precone, Mariano Franco Corrado, Antonio De Luna, Filomena Morisco, Silvia Camera, Alessandro Federico, Marcello Dallio et al. · 2017 · Antiviral Therapy
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
Youwen Tan, Xing-Bei Zhou, Yun Ye, Cong He, Guohong Ge · 2017 · World Journal of Gastroenterology
Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study
Richard K. Sterling, Abdus S. Wahed, Wendy C. King, David Erwin Kleiner, Mandana Khalili, Mark Sulkowski, Raymond T. Chung, Mamta K. Jain, Mauricio Lisker‐Melman, David Wong et al. · 2018 · The American Journal of Gastroenterology
Comparison of FIB-4 Index and Child-Pugh Score in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma
Pan Zhou, Bo Chen, Xiongying Miao, Jiangjiao Zhou, Li Xiong, Yu Wen, Heng Zou · 2019 · Journal of Gastrointestinal Surgery
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
Carlo Smirne, Cristina Rigamonti, Carla De Benedittis, Pier Paolo Sainaghi, Mattia Bellan, Michela Emma Burlone, Luigi Mario Castello, Gian Carlo Avanzi · 2019 · Disease Markers
Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB‐4 for staging liver fibrosis in chronic viral hepatitis
Prowpanga Udompap, Kamonthip Sukonrut, Voraparee Suvannarerg, Ananya Pongpaibul, Phunchai Charatcharoenwitthaya · 2019 · Journal of Viral Hepatitis
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
Janae Wentong Wai, Charmaine Fu, Vincent Wai‐Sun Wong · 2020 · Journal of Gastroenterology
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi, Kota Tsuruya, Kazuya Anzai, Yoshitaka Arase, Koichi Shiraishi, Michiko Suzuki, Satsuki Ieda, Tatehiro Kagawa · 2020 · PLoS ONE
Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention
Hui‐Hui Liu, Ye‐Xuan Cao, Jing‐Lu Jin, Qi Hua, Yanfang Li, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Runlin Gao, Jian‐Jun Li · 2021 · Journal of the American Heart Association
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.
L. Tang, Hong-Lei Ma, M. Eslam, G. Wong, Pei-Wu Zhu, Sui-Dan Chen, D. Leeming, M. Karsdal, Gang Li, Ou-Yang Huang et al. · 2021 · Metabolism: Clinical and Experimental
Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac‐2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis
Tatsunori Hanai, Makoto Shiraki, Sachiyo Ohnishi, Tsuneyuki Miyazaki, Takayasu Ideta, Takahiro Kochi, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu et al. · 2015 · Hepatology Research
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
Chen‐Hua Liu, Chi-Yi Chen, Wei‐Wen Su, Kuo‐Chih Tseng, Gin‐Ho Lo, Chun‐Jen Liu, Jyh-Jou Chen, Cheng‐Yuan Peng, Yu‐Lueng Shih, Sheng‐Shun Yang et al. · 2021 · Gut
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
Guri Fossdal, Anders Batman Mjelle, Kristine Wiencke, Ida Bjørk, Odd Helge Gilja, Trine Folseraas, Tom H. Karlsen, William M. Rosenberg, Lasse Melvaer Giil, Mette Nåmdal Vesterhus · 2021 · JHEP Reports
Risk factors for Fontan-associated hepatocellular carcinoma
Tomomi Kogiso, Takaomi Sagawa, Makiko Taniai, Eriko Shimada, Kei Inai, Tokuko Shinohara, Katsutoshi Tokushige · 2022 · PLoS ONE
Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulation
Sin Man Lam, Zehua Wang, Jin‐Wen Song, Yue Shi, Wen‐Yue Liu, Li Wan, Kaibo Duan, Gek Huey Chua, Yingjuan Zhou, Guibin Wang et al. · 2024 · Cell Metabolism
A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD
Paul Calès, Clémence M. Canivet, Charlotte E. Costentin, Adrien Lannes, Frédéric Oberti, Isabelle Fouchard, Gilles Hunault, Victor de Lédinghen, Jérôme Boursier · 2024 · Journal of Hepatology
Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study
Stuart C. Gordon, Lois E. Lamerato, Loralee B. Rupp, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Fujie Xu, Joseph A. Boscarino, Vinutha Vijayadeva et al. · 2015 · The American Journal of Gastroenterology
Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy
Katherine W. Kooij, Ferdinand W.N.M. Wit, Rosan A van Zoest, J. Schouten, Neeltje A. Kootstra, Michèle van Vugt, Maria Prins, Peter Reiss, Marc van der Valk · 2016 · AIDS
Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population
Mariana Lazo, Chizoba N. Nwankwo, Natalie Rula Daya, David L. Thomas, Shruti H. Mehta, Stephen Paul Juraschek, Kerry Willis, Elizabeth Selvin · 2017 · Clinical Gastroenterology and Hepatology
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration
Yuval A. Patel, Elizabeth J. Gifford, Lisa M. Glass, Marsha J. Turner, Byungjoo Han, Cynthia A. Moylan, Steve S. Choi, Ayako Suzuki, Dawn Provenzale, Christine M. Hunt · 2018 · Digestive Diseases and Sciences
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
Kentaro Matsuura, Nobuhiro Aizawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hidenori Toyoda, Takashi Kumada, Etsuko Iio, Kyoko Ito, Shintaro Ogawa, Masanori Isogawa et al. · 2018 · Open Forum Infectious Diseases
The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study
Fuad Jafarov, Eda Kaya, Alev Bakır, Fatih Eren, Yusuf Nadir Yilmaz · 2019 · European Journal of Gastroenterology & Hepatology
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease
Flavia Agata Cimini, Ilaria Barchetta, Gea Ciccarelli, Frida Leonetti, Gianfranço Silecchia, Caterina Chiappetta, Claudio Di Cristofano, Danila Capoccia, Laura Bertoccini, Valentina Ceccarelli et al. · 2020 · Diabetes/Metabolism Research and Reviews
Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Masahiro Ogawa, Shunichi Matsuoka, Seth J. Karp, Mitsuhiko Moriyama · 2020 · International Journal of Molecular Sciences
A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
Fredrik O. Åberg, Christopher J. Danford, Maja Sofie Thiele, Mats Talbäck, Ditlev Nytoft Rasmussen, Zhenghui Gordon Jiang, Niklas Hammar, Patrik Nasr, Mattias Ekstedt, Anna But et al. · 2021 · Hepatology Communications
Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid–enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS
Ho Jun Lee, Seung Baek Hong, Nam Kyung Lee, Suk Kim, Hyung Il Seo, Dong Uk Kim, Sung Yong Han, Ki Suk Choo · 2021 · European Radiology
Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center
Yun Hwa Roh, Bo-Kyeong Kang, Dae Won Jun, Chul‐min Lee, Mimi Kim · 2021 · Scientific Reports
. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.
Park, Lesley S., Tate, Janet P., Justice, Amy C., Lo Re, Vincent, Lim, Joseph K., Bräu, Norbert, Brown, Sheldon T., Butt, Adeel A., Gibert, Cynthia, Goetz, Matthew Bidwell et al. · 2011 · Cancer Epidemiology, Biomarkers & Prevention
Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study
Samer Gawrieh, Jordan E. Lake, Paula Debroy, Julia A. Sjoquist, Montreca Robison, Mark A. Tann, Fatih M. Akisik, Surya Sruthi Bhamidipalli, Chandan Saha, Kimon C. Zachary et al. · 2023 · Hepatology
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study
Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka et al. · 2023 · Hepatology Research
Exercise improves surrogate measures of liver histological response in metabolic dysfunction‐associated steatotic liver disease
Cuthbertson, Daniel J., Keating, Shelley E., Pugh, Christopher J. A., Owen, Patrick J., Kemp, Graham J., Umpleby, Margot, Geyer, Nathaniel G., Chinchilli, Vernon M., Stine, Jonathan G. · 2024 · Liver International
A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection
Bahadır Ceylan, Bilgül Mete, Muzaffer Fıncancı, Turan Aslan, Yasemin Akkoyunlu, Nail Özgüneş, Onur Çolak, Alper Gündüz, Ebubekir Şenateş, Reşat Özaras et al. · 2013 · Wiener klinische Wochenschrift
Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining
Keito Yoshimura, Takeshi Okanoue, Hayao Ebise, Tsuyoshi Iwasaki, Masayuki Mizuno, Toshihide Shima, Junji Ichihara, Kazuto Yamazaki · 2015 · Hepatology
APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology
Alcindo Pissaia, Didier Borderie, Denis Bernard, Olivier Scatton, Yvon Calmus, Filoména Conti · 2009 · Transplantation Proceedings
Ultrasound elastography: liver
Manish Dhyani, Arash Anvari, Anthony E. Samir · 2015 · Abdominal Imaging
Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma
Yukihiro Okuda, Kojiro Taura, Kenji Yoshino, Yoshinobu Ikeno, Takahiro Nishio, Gen Yamamoto, Kazutaka Tanabe, Yukinori Koyama, Etsuro Hatano, Shiro Tanaka et al. · 2016 · Annals of Surgery
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study
Helen Kovari, Andri Rauch, Roger D. Kouyos, Mathieu Rougemont, Matthias L. Cavassini, Patrick Schmid, M Stöckle, Enos Bernasconi, Rainer K. Weber, Bruno Ledergerber et al. · 2016 · Clinical Infectious Diseases
CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C
Julien Vergniol, Juliette Foucher, Éric Terrebonne, Brigitte Le Bail, Wassil Merrouche, Patrice Couzigou, Victor de Lédinghen · 2011
Unexplained chronic liver disease in Ethiopia: a cross-sectional study
Stian Magnus Staurung Orlien, Nejib Yusuf Ismael, Tekabe Abdosh Ahmed, Nega Berhe, Trine Lauritzen, Borghild Roald, Robert David Goldin, Kathrine Stene‐Johansen, Anne Margarita Dyrhol-Riise, Svein Gunnar Gundersen et al. · 2018 · BMC Gastroenterology
Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4
Adel Abdel‐Moneim, Alaa Aboud, Mohammed Abdel‐Gabbar, Mohamed Ibrahim Zanaty, Mohamed Ramadan · 2018 · Hepatology International
Long‐term changes in liver elasticity in hepatitis C virus‐infected patients with sustained virologic response after treatment with direct‐acting antivirals
V. Pietsch, Katja Deterding, Dina Ismail Attia, Kristina Imeen Ringe, Benjamin Heidrich, Markus Cornberg, M Gebel, Michael Peter Manns, Heiner H. Wedemeyer, Andrej Potthoff · 2018 · United European Gastroenterology Journal
Gender differences for frailty in HIV-infected patients on stable antiretroviral therapy and with an undetectable viral load
José Ramón Blanco, Inmaculada Barrio, Enrique Ramalle Gómara, María Isabel Beltran, Valvanera Ibarra, Luís Metola, Mercedes Sanz, José Antonio Oteo, Estrella Melús, Lucía Antón · 2019 · PLoS ONE
Liver disease secondary to congenital heart disease in children
Haruki Komatsu, Ayano Inui, Kanako Kishiki, Hironari Kawai, Sachiyo Yoshio, Yosuke Osawa, Tatsuya Kanto, Tomoo Fujisawa · 2019 · Expert Review of Gastroenterology & Hepatology
Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease
Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, Sakura Kirino, Leona Osawa, Keiya Watakabe, Wan Wang, Mao Okada, Takao Shimizu, Kenta Takaura et al. · 2019 · Scientific Reports
Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
Xu Li, Hongqin Xu, Pujun Gao · 2019 · Medical Science Monitor
Vibration‐controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection
Ben L. Da, Pallavi Surana, Varun K. Takyar, David Erwin Kleiner, Theo Heller, Christopher Koh · 2019 · Journal of Viral Hepatitis
Long‐term outcomes of non‐alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population
Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige · 2020 · Journal of Gastroenterology and Hepatology
Non-invasive tests for the prediction of primary hepatocellular carcinoma
Giovanni Marasco, Antonio Colecchia, Giovanni Faria Silva, Benedetta Rossini, Leonardo Henry Eusebi, Federico Ravaioli, Elton Dajti, Luigina Vanessa Alemanni, Luigi Colecchia, Matteo Renzulli et al. · 2020 · World Journal of Gastroenterology
Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
Christiana Graf, Tania Mara Welzel, Dimitra Bogdanou, Johannes Vermehren, Anita Beckel, Jörg Bojunga, Mireen Friedrich‐Rust, Julia Dietz, Alica Kubesch, A. W. Mondorf et al. · 2020 · Journal of Clinical Medicine
Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis
Maciej K. Janik, Beata Kruk, Benedykt Szczepankiewicz, Konrad Kostrzewa, Joanna Raszeja‐Wyszomirska, Barbara Górnicka, Frank Lammert, Piotr Milkiewicz, Marcin Jan Krawczyk · 2020 · Liver International
Gastroesophageal varices evaluation using spleen‐dedicated stiffness measurement by vibration‐controlled transient elastography
Koki Nagai, Yuji Ogawa, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yusuke Saigusa, Kento Imajo, Masato Yoneda et al. · 2021 · JGH Open
Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care
Victoria Blanes‐Vidal, Katrine Prier Lindvig, Maja Sofie Thiele, Esmaeil S. Nadimi, Aleksander Ahm Krag · 2022 · Scientific Reports
Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS
Angel N. Borisov, Alexander Kutz, Emanuel Christ, Markus Hermann Heim, Fahim Ebrahimi · 2023 · The Journal of Clinical Endocrinology & Metabolism
Quality of Life, Symptomatology and Healthcare Utilization in HIV/HCV Co-Infected Drug Users in Miami
Marianna K. Baum, Dushyantha T. Jayaweera, Rui Duan, Sabrina Sales, Shenghan Lai, Carlin L. Rafie, Arie Regev, John Bryan Page, Ronald Berkman, Adriana L. Campa · 2008 · Journal of Addictive Diseases
Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients
Somaya Hashem, Gamal Esmat, Wafaa Elakel, Shahira M. Habashy, Safaa Abdel Raouf, Samar Kamal Darweesh, Mohamad H. Soliman, Mahmoud ElHefnawi, Mohamed Eladawy, Mahmoud ElHefnawi · 2016 · Gastroenterology Research and Practice
Noninvasive Diagnosis of Hepatic Fibrosis in HIV/HCV-Coinfected Patients
María Larrousse, Montserrat Laguno, Marta Segarra, Elisa de Lazzari, Estebán Martínez, José Luís Blanco, Agathe León, Ramón Deulofeu, Rosa Miquel, Ana Milinkovic et al. · 2007 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
Kechagias, Stergios, Ekstedt, Mattias, Simonsson, Christian, Nasr, Patrik · 2022 · Hormones
Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer
Yan Lv, Haijun Zhang · 2020 · Frontiers in Oncology
Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial
Yufeng Xing, Weichao Zhong, Deti Peng, Zhiyi Han, Hua Zeng, Yanqing Wang, Lian Feng, Jinzhen Huang, Linyi Xu, Mingtai Chen et al. · 2023 · Pharmacological Research
Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Xinyu Zhang, Chenyu Zhu, Luyi Tan, Hui Lin, Wenjuan Zhang, Wenji Zhang · 2023 · Annals of Medicine
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Jonas Santol, Sarang Kim, Lindsey A. Gregory, Ruth Baumgartner, Anastasia Murtha-Lemekhova, Emrullah Birgin, Severin Gloor, Eva Braunwarth, M. Ammann, Johannes Starlinger et al. · 2023 · Annals of Surgery
Developing and validating clinical prediction models in hepatology – An overview for clinicians
Rickard Strandberg, Peter Jepsen, Hannes Hagström · 2024 · Journal of Hepatology
An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients
Salvador Resino, José Antonio Seoane, José María Bellón, Julián Dorado, Fernando J. Martin-Sanchez, Emilio Fernández Álvarez, Jaime Cosín, Juan Carlos López, Guilllermo Lopéz, Pilar Miralles et al. · 2010 · Journal of Infection
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection
Jennifer L. Grant, Claudia Hawkins, Hannah Brooks, Frank Joseph Palella, Sean Koppe, Michael M. Abecassis, Valentina Stosor · 2015 · AIDS
Predictors of transitions in frailty severity and mortality among people aging with HIV
Thomas D. Brothers, Susan Kirkland, Olga Theou, Stefano Zona, Andrea Malagoli, Lindsay M. K. Wallace, Chiara Stentarelli, Cristina Mussini, Julian Falutz, Giovanni Guaraldi et al. · 2017 · PLoS ONE
Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
Mattia Bellan, Luigi Mario Castello, Mario Pirisi · 2018 · Journal of Clinical and Translational Hepatology
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease
Kenichi Tanaka, Hirokazu Takahashi, Hideyuki Hyogo, Masafumi Ono, Noriko Oza, Yoichiro Kitajima, Miwa Kawanaka, Kazuaki Chayama, Toshiji Saibara, Keizo Anzai et al. · 2018 · Hepatology Research
Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study
Deirdre L. Sawinski, Kimberly A. Forde, Vincent Lo Re, David Seth Goldberg, Jordana B. Cohen, Jayme E. Locke, Roy D. Bloom, Colleen M Brensinger, Joe Weldon, Justine Shults A et al. · 2019 · American Journal of Kidney Diseases
Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
Masahito Nakano, Hironori Koga, Tatsuya Ide, Ryoko Kuromatsu, Satoru Hashimoto, Hiroshi Yatsuhashi, Masataka Seike, Nobito Higuchi, Makoto Nakamuta, Satoshi Shakado et al. · 2019 · Cancer Medicine
Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999–2016
Biyao Zou, Yee Hui Yeo, Michael Huan Le, Linda L Henry, Ellen T. Chang, Anna Suk-Fong Lok, Ramsey C Cheung, Mindie H. Nguyen · 2019 · The Journal of Infectious Diseases
Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India
Harit G. Kothari, Sudhir Jagdishoprasad Gupta, Nitin Gaikwad, Tushar Hiralal Sankalecha, Amol Rajendra Samarth · 2019 · The Turkish Journal of Gastroenterology
Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study
Takuya Kuwashiro, Hirokazu Takahashi, Hideyuki Hyogo, Yuji Ogawa, Kento Imajo, Masato Yoneda, Takashi Nakahara, Satoshi Oeda, Kenichi Tanaka, Yuichiro Amano et al. · 2019 · JGH Open
The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D
Ben L. Da, Pallavi Surana, David Erwin Kleiner, Theo Heller, Christopher Koh · 2019 · Antiviral Research
Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐ aspartate aminotransferase score
Takeshi Hatanaka, Takashi Kosone, Naoto Saito, Satoshi Takakusagi, Hiroki Tojima, Atsushi Naganuma, Hitoshi Takagi, Toshio Uraoka, Satoru Kakizaki · 2021 · JGH Open
Identification of liver disease: why and how
Iain S MacPherson, Kushala W. M. Abeysekera, Rebecca Harris, Dina Mansour, Stuart McPherson, Ian A.C. Rowe, William M. Rosenberg, John Francis Dillon, Andrew D. Yeoman · 2022 · Frontline Gastroenterology
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease
Veeral H. Ajmera, Khang Nguyen, Nobuharu Tamaki, Suzanne R. Sharpton, Ricki Bettencourt, Rohit Seth Loomba · 2022 · Therapeutic Advances in Gastroenterology
Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population
Udompap, Prowpanga, Therneau, Terry M., Canning, Rachel E., Benson, Joanne T., Allen, Alina M. · 2023 · Hepatology
FIB-4 Index is a Predictor of Background Liver Fibrosis and Long-Term Outcomes After Curative Resection of Hepatocellular Carcinoma
Yukiyasu Okamura, Ryo Ashida, Yusuke Yamamoto, Takaaki Ito, Teiichi Sugiura, Katsuhiko Uesaka · 2016 · Annals of Surgical Oncology
Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: Comparison of the APRI and FIB-4 index
Tony Trang, John R. Petersen, Ned Snyder · 2008 · Clinica Chimica Acta
Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study
Jitao Wang, Tianlei Zheng, Yong Liao, Shi Geng, Jinlong Li, Zhanguo Zhang, Dong Shang, Chengyu Liu, Peng Cheng Yu, Yifei Huang et al. · 2022 · Frontiers in Oncology
Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease
Irene Martín de Miguel, Patrick S. Kamath, Alexander C. Egbe, Christopher Charles Jain, Frank Cetta, Heidi M. Connolly, William R. Miranda · 2022 · Heart
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
Veeral H. Ajmera, Kaleb Tesfai, Erick Sandoval, Scarlett J. Lopez, Vanessa Cervantes, Egbert V. Madamba, Ricki Bettencourt, Pinelopi Manousou, Lisa Richards, Rohit Seth Loomba · 2023 · Hepatology
Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005–2023)
Hamed Zamanian, Ahmad Shalbaf, Mohammad Reza Zali, A.R. Khalaj, Pooneh Dehghan, Mastaneh Rajabian Tabesh, Behzad Hatami, Roohallah Alizadehsani, Ru‐San Tan, U. Rajendra Acharya · 2023 · Computer Methods and Programs in Biomedicine
Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease
Laura Kalveram, Ulrich Baumann, Ruth De Bruyne, Laura G. Draijer, Wojciech Jańczyk, Deirdre Anne Kelly, Bart G.P. Koot, Florence Lacaille, Sander Lefere, Hadar Moran‐Lev et al. · 2023 · Journal of Pediatric Gastroenterology and Nutrition